Billionaire Profile
Zhong Huijuan
Global Rank
#127

Image: Unsplash Contributor | Unsplash License | via Unsplash

Zhong Huijuan

CEO, Pharmaceuticals
CHINA
Real-Time Net Worth
$21.188B
Estimated based on Pharmaceuticals stock value as of April 20, 2026
+0.33% (24h)
Age
65
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
CHINA

Biography

Zhong Huijuan, a prominent figure in the pharmaceutical industry, is the founder, CEO, and chair of Hansoh Pharmaceutical Group. Born in 1961, she holds a Bachelor of Science degree from Jiangsu Normal University and an EMBA from Nanjing University. Before her entrepreneurial journey, she was a chemistry teacher. Her career shift in 1995 to establish Hansoh Pharmaceutical, with a focus on oncology, CNS diseases, and metabolic disorders, propelled her to become one of the wealthiest self-made women globally. With a net worth of $18.4 billion, she has demonstrated a commitment to innovation, evidenced by substantial investments in research and development, solidifying her as a leader in the healthcare sector.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life

Zhong Huijuan was born in April 1961, in Lianyungang, Jiangsu Province, China. She earned a Bachelor's degree in Chemistry from Jiangsu Normal University in July 1982. After graduating, she started her career as a chemistry teacher at Yan'an Middle School in Lianyungang.

Rise to Success

In 1995, Zhong transitioned from teaching to entrepreneurship. She founded Hansoh Pharmaceutical Group with a team of just ten employees. The company focused on research, development, manufacturing, and sales of drugs for various diseases, including cancer, infectious diseases, and diabetes. Under her leadership, the company invested heavily in research and development. In 1997, the company reached $4.5 million in revenue, which has been growing ever since. In June 2019, Hansoh Pharmaceutical had its initial public offering on the Hong Kong Stock Exchange, raising approximately $1 billion. This significantly increased her wealth and solidified her position in the pharmaceutical industry.

Key Business Strategies

Zhong Huijuan's success is attributed to several key strategies. A primary focus has been on innovation, with Hansoh investing a significant portion of its revenue into research and development. The company also secured licensing deals with global pharmaceutical giants such as Roche, Merck, and GSK, for co-developing drugs. Moreover, Zhong has a long-term vision, committing to sustainable growth, and building a lasting competitive advantage through innovation. The company has a robust pipeline of drugs, with several innovative drugs already generating sales revenue.

Philanthropy

Zhong Huijuan's philanthropy is not extensively detailed in the search results. However, as a leader, she integrates ESG principles with the company's long-term strategy, maintaining an AA rating in the MSCI ESG rating and achieving industry-leading standards in corporate behavior and governance.

Career Milestones

1982

Graduated from Jiangsu Normal University

Obtained a degree in chemistry.

1995

Founded Hansoh Pharmaceutical Group

Transitioned from a chemistry teacher to an entrepreneur by founding Hansoh Pharmaceutical Group.

2019

Hansoh Pharmaceutical IPO

Hansoh Pharmaceutical went public on the Hong Kong Stock Exchange, raising approximately $1 billion.

Philanthropy & Social Impact

Corporate Social Responsibility

Not publicly specified

Undisclosed

Hansoh integrates ESG principles into its long-term strategy, maintaining an AA rating in the MSCI ESG rating.

Business Philosophy & Leadership

Leadership Principles

Commitment to Innovation

Prioritizing and investing heavily in research and development to create new drugs.

Long-Term Vision

Focusing on sustainable growth by investing in innovation and building a lasting competitive advantage.